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Nonspecific granuloma of the larynx is a benign tumor that usually occurs on the poste-
rior glottis. Conventional treatment for this laryngeal lesion has consisted of surgical
resection. However, this lesion has a strong tendency to recur postoperatively and may
require multiple repeated operative procedures. Conservative treatment, consisting
mainly of beclomethasone dipropionate inhalation therapy, was instituted in 20 cases
with good results. We discussed the effect of beclomethasone dipropionate on this lesion
as well as the etiology of this disease.
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INTRODUCTION SUBJECTS
Nonspecific granuloma of the larynx is a benign tumor
that usually occurs on the posterior glottis.
Recurrences frequently occur even when these granu-
lomas are surgically resected and it is not rare for mul-
tiple repeated operations to be required. Therefore,
conservative treatment using primarily a beclometha-
sone dipropionate inhaler (Aldecine(R) inhaler) was
instituted in 20 cases of nonspecific granuloma of the
larynx with good results. The results are discussed in
this paper, and we have attempted to explain the
mechanism of therapeutic efficacy and the etiology of
the disease.
Among the patients with nonspecific granuloma of the
larynx who presented to the ENT clinic of Tokyo
Metropolitan Ohtsuka Hospital in the 7 years between
April 1988 and March 1995, the 20 patients who
underwent conservative therapy and were followed up
for 6 months were selected as subjects of this study.
Clinical characteristics and therapeutic results of these
patients were evaluated (Table I). The subjects
included 3 patients with post-intubation granuloma
that developed after endotracheal intubation and 17
patients with idiopathic granuloma unrelated to endo-
tracheal intubation. Median patient age at time of the
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TABLE Clinical characteristics and therapeutic results of beclomethasone dipropionate inhalation therapy
Patient Age at Sex Chief Idiopathic or Site Time of Past
No. Diagnosis Complaints Post-intubation Disappearance History
(yr) (months)
Efficacy
66 Male Cough Idiopathic Left 3 months Diabetes
hoarseness mellitus
2 71 Male AST, cough Idiopathic Left month (-)
hoarseness
3 64 Female Cough Post-intubation Left 3 months and
hoarseness 2 weeks
4 42 Male AST, cough Idiopathic Right month and
2 weeks
5 21 Female AST, Post-intubation
hoarseness
6 44 Male AST, cough Idiopathic
hoarseness
7 50 Male Cough Idiopathic
hoarseness
8 55 Female AST, cough Idiopathic
9 44 Male AST Idiopathic
Right 5 months
Left 8 months
Left 3 months
Left 3 months
Left 24 months
10 39 Male AST, Idiopathic Left 5 months
hoarseness
11 52 Male AST, Idiopathic Left 5 months
12 45 Male AST, cough Idiopathic Right 4 months
13 49 Male AST, Idiopathic Right 2 months
14 33 Male AST, Idiopathic Left Residual on
21 months
15 50 Male AST, cough Post-intubation Bilateral 3 months
hoarseness
16 46 Male AST, cough Idiopathic Right Residual on
hoarseness 12 months
17 49 Male AST, Idiopathic Left Residual on
12 months
18 52 Male AST, cough Idiopathic Right Residual on
7 months
19 74 Male AST, cough Idiopathic Right 2 months
hoarseness
20 50 Male Hoarsen Idiopathic Left 2 months
Colon
carcinoma
(-)
Head injury
Granuloma
reaction
(-)
(-)
Granuloma
resection
(-)
(-)
(-)
(-)
Granuloma
resection
Vertebral
tumor
(-)
(-)
(-)
(-)
(-)
AST: abnormal sensation in the throat, E: excellent, G: good, F: fair, P: poor
initial examination was 49.8 years, with a range from
21 to 74 years. There were 17 men and 3 women. All
of the granulomas were located on the vocal process of
the arytenoid cartilage. The granulomas had devel-
oped on the right side in 7 cases, left side in 12 cases
and bilaterally in 1 case. Common symptoms included
an abnormal sensation in the throat, cough and hoarse-
ness. In some cases, coughing and throat-clearingTHERAPY FOR LARYNGEAL GRANULOMA 95
appeared first, followed by an abnormal sensation in
the throat and hoarseness. Three patients, all of them
with idiopathic granuloma, were referred to our clinic
because of recurrence following resection at another
hospital, and the definitive histopathological diagnosis
was nonspecific granuloma of the larynx.
TREATMENT METHOD AND
ASSESSMENT OF EFFICACY
All of the subjects underwent beclomethasone dipro-
pionate inhalation therapy as outpatients. The inhaler
contained a suspension of beclomethasone dipropi-
onate, whose structural formula is shown in Figure. 1,
sealed in an atomizer. The atomizer releases approxi-
mately 0.05 mg per spray. Two inhalations (a dose of
approximately 0.1 mg) were given four times a day
based on the protocol for the treatment of bronchial
asthma. All of the patients were instructed to refrain
from unnecessary coughing and loud talking.
Therapeutic efficacy was assessed by local findings
in the larynx observed with a laryngoendoscope. We
established our own assessment criteria for therapeutic
efficacy, classifying the results as excellent, good,
fair, or poor (Table II).
RESULTS
Table I shows the results of the assessment of the ther-
apeutic efficacy. The response was excellent in 9
patients, good in 5, fair in 2, and poor in 4. Fourteen
patients had an excellent or good response, for an effi-
cacy rate of 70%. Six patients had a fair or poor
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FIGURE Structural formula of beclomethasone of dipropionate.
TABLE II Criteria for assessment of efficacy of beclomethasone
dipropionate inhalation therapy in nonspecific granuloma of the
larynx
Excellent: Complete disappearance of the lesion within 3 months
of the start of inhalation therapy
Good: Reduction in size of the lesion within 3 months of the start
to inhalation therapy and complete disappearance of the lesion
within 6 months
Fair: Reduction in size of the lesion within 3 months, but residual
lesion observed after 6 months of inhalation therapy
Poor: No change after 3 months of inhalation therapy
The therapeutic efficacy was established by assessment based on
laryngoendoscopic findings.
response, but three ofthem had a recurrence following
surgical resection at other hospitals prior to referral to
our clinic. All of the lesions eventually resolved
except 4 patients who had showed a poor response,
and none of the 16 patients with completely resolved
lesions have experienced subsequent recurrences.
CASE PRESENTATION
One of the 20 patients who had an excellent response is
presented here. Patient number 7 was a 50-year-old
man whose chief complaint was coughing and hoarse-
ness. He developed a mild cough in January 1990, and
complained of hoarseness that made it difficult to pro-
duce a high-pitched voice in July 1990. He first pre-
sented to our clinic in August 1991. Flexible
laryngofiberscopy revealed a grayish-white, spherical
mass observed on the left vocal process ofthe arytenoid
cartilage (Figure 2-a). Since the lesion appeared to be
an idiopathic nonspecific granuloma of the larynx,
beclomethasone dipropionate inhalation therapy was
started. After approximately 1 week, his symptoms
gradually improved, and after 4 weeks of inhalation
therapy, the site of lesion had been reduced by approx-
imately 50% (Figure 2-b). A reduction in size of
approximately 75% was observed after 8 weeks (Figure
2-c). At the end of 12 weeks, the symptoms of cough-
ing and hoarseness had resolved, and flexible laryn-
gofiberscop revealed no evidence ofthe lesion (Figure
2-d). The patient has not experienced any recurrences.96 M. KAWAIDA et al.
FIGURE 2 Flexible laryngofiberscopic findings in a patient with idiopathic nonspecific granuloma of the larynx, a (Initial findings), A gray-
ish white, spherical mass observed on the left vocal process, b (After4 weeks of treatment), The lesion has reduced in size approximately 50%.
c (After 8 weeks of treatmenr), The lesion had reduced in size approximately 75%. d (After 12 weeks of treatment), The lesion had completely
disappeared.
DISCUSSION
The most common types of nonspecific granuloma of
the larynx are post-intubation granuloma and idio-
pathic granuloma unrelated to endotracheal intubation.
Surgical resection has been the treatment of first
choice. Patients seldom experience recurrences after
surgical resection of post-intubation granulomas.
Patients with idiopathic granulomas, however, often
present with repeated recurrences postoperatively
1,2]. It has been suggested that surgical resection may
actually promote the development of these granulo-
mas. Therefore, treatment of such granulomas by con-
servative therapy might reduce the recurrence rate.
Excessive hard attacks of the posterior glottis due to
coughing and habitual throat-clearing has been
reported to be a possible cause of idiopathic granuloma
of the larynx [3,4]. Cough was a chief complaint in 10
of the 17 patients with idiopathic granuloma in our
study. In patients without coughing or habitual throat-
clearing, the most common chief complaint was an
abnormal sensation in the throat, and these patients
may have often cleared their throats unconsciously.
Two of the three patients with post-intubation granu-
loma complained of coughing, and it appears that the
cause may not have been only the intubation procedure
itself but also excessive hard attacks of the posterior
glottis during coughing as a result of airway irritation
from the procedure. Thus, granulation tissue in idio-
pathic granuloma likely develops secondary to micro-
trauma and perichondritis of the vocal process of the
arytenoid cartilage because of excessive hard glottalTHERAPY FOR LARYNGEAL GRANULOMA 97
attacks caused by coughing, habitual throat-clearing,
voice abuse, or esophago-pharyngeal acid reflux [5].
Once an idiopathic or post-intubation granuloma
has developed, the granulomatous lesion itself may
irritate the airways mechanically, inducing more
coughing and throat-clearing. Natural healing, which
would occur in the absence of mechanical irritation,
also seems to be hindered by excessive hard attacks of
the posterior glottis because of coughing and habitual
throat-clearing. The traditional treatment of choice
mainly has been maintenance of silence or voice ther-
apy [3,6-8]. However, because prolonged silence is
impractical for many patients, and because neoplasm
cannot be excluded without a definitive histopatholog-
ical diagnosis, surgical resection has become the treat-
ment of choice.
The utility of beclomethasone dipropionate inhala-
tion therapy in the treatment of nonspecific granuloma
of the larynx was first reported in 1989 [9]. A total of
20 patients have been treated with beclomethasone
dipropionate inhalation therapy in our clinic, and they
comprise the subjects of the present study. The fact
that the granulomatous lesion eventually disappeared
in 16 patients is consistent with the efficacy of this
inhalation therapy. The mechanism of action of this
inhalation therapy will be discussed below.
Nonspecific granuloma of the larynx results mainly
from inflammatory granulation tissue proliferation
[10]. Drugs with potent anti-inflammatory action,
such as corticosteroids, should be capable of inhibiting
granulation and should cause the lesion to resolve. In
addition, such drugs also act on the airways to sup-
press nonspecific inflammation and reduce airway
hypersensitivity [11,12]. This inhalation therapy
reduces the need for coughing and throat-clearing,
thus eliminating mechanical irritation associated with
excessive hard attacks of the posterior glottis. It
appears that excessive hard attacks of the posterior
glottis persisted in "poor response" patients, who
failed to beclomethasone dipropionate inhalation ther-
apy, such as in patients in whom habitual throat-
cleating did not improve.
Beclomethasone dipropionate is applied topically,
and the risk of adverse reactions occurring with corti-
costeroid inhalation therapy must be considered.
However, few adverse reactions typically caused by
systemic glucocorticoid action occur at the therapeutic
dose, and the inhaler is easy for outpatient to use
because of the quantitative atomizer [13-15]. All 20
patients used the inhaler on an outpatient basis with no
adverse reactions.
Nonspecific granuloma of the larynx most often
arises on the posterior glottis, and laryngoendoscopic
diagnosis is generally easy in many cases. However,
these lesions must be differentiated from neoplasms
such as laryngeal carcinoma and papilloma.
Therefore, when no abnormal findings exist on gen-
eral examination and clinical suspicion of nonspecific
granuloma is high, the treatment plan described below
is used in our clinic.
Conservative therapy predominantly using a
beclomethasone dipropionate inhaler is prescribed for
3 months for both idiopathic and post-intubation gran-
uloma. In addition, unnecessary throat-clearing is dis-
couraged, and patients are instructed to refrain from
loud talking and to remain silent whenever possible. If
the size of the lesion diminishes after 3 months, con-
servative therapy is continued for another 3 months
and the patient’s course is followed. If, however, the
lesion has not resolved after 6 months, or ifno changes
occur after the first three months, the lesion is resected
surgically and examined histopathologically.
To definitively evaluate the utility of beclometha-
sone dipropionate inhalation therapy in the treatment
of nonspecific granuloma of the larynx, it seems nec-
essary to compare its therapeutic efficacy in a group
treated conservatively with inhalation therapy and a
group treated conservatively without inhalation ther-
apy. We are thus planning to increase the number of
cases and perform a controlled study in two such
groups. Although long-term follow-up results are also
unavailable for evaluating the utility of this inhalation
therapy, it appears preliminarily to be worth while
prior to attempting surgical resection.
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